Although DC recruitment into the tumor bed is mainly mediated by additional chemokines and ATP, ANXA1 guides DCs towards dying cancer cells by interacting with formyl peptide receptor 1 (FPR1) [50]. Here, FPR1 is linked to neoplasm.